Key result
Circulating adiponectin inversely links to adiposity but promotes in vitro fat browning attenuated by BDNF.
Why the study?
Obesity is a major global epidemic, but the roles of adiponectin and brain-derived neurotrophic factor (BDNF) in adiposity have not been clearly defined.
Do adiponectin and BDNF regulate adiposity and fat browning?
Observational
Do adiponectin and BDNF regulate adiposity and fat browning?
Adiponectin and BDNF play contrasting roles in regulating fat mass and fat-browning, suggesting circulating adiponectin could be a monitoring index for obesity.
Answers are grounded in this paper and cite their sources.
May support adiponectin as obesity monitoring index in women; leaves open causal roles of adiponectin and BDNF in fat browning.
Obesity, characterized by excessive fat mass, has been emerging as a major global epidemic and contributes to the increased risk of morbidity around the world. Thus, the necessity to find effective therapy and specific regulatory mechanisms is increasing for controlling obesity. Lately, many researchers have been interested in the linkage between obesity and adipokines/myokines, particularly adiponectin and brain-derived neurotrophic factor (BDNF). However, the role of adiponectin and BDNF in adiposity has not been clearly defined yet. We examined the association of adiposity with adiponectin and BDNF through human study (observational study) with Korean women and in vitro experiments. In the human study, we found a negative relationship between adiposity and circulating adiponectins but irregular patterns in the relationship between adiposity and circulating BDNFs. In the in vitro study using 3T3-L1 adipocytes, adiponectin treatment strongly promoted adipocyte differentiation and the fat browning process, whereas BDNF treatment attenuated adipocyte differentiation and the fat browning process in differentiated adipocytes. Our results demonstrate that adiponectin and BDNF play an important role in regulating fat mass and the expression of fat-browning markers in different ways, and also suggest that circulating adiponectin may be used as an important monitoring index for obesity status.
No takes yet. Share an insight, caveat, or question.
Jo et al. (2020) conducted an observational in Obesity. Adiponectin and BDNF was evaluated on Association of adiposity with adiponectin and BDNF. Circulating adiponectin showed a negative relationship with adiposity in Korean women, while in vitro adiponectin promoted and BDNF attenuated adipocyte differentiation and fat browning.
Synapse has enriched 10 related papers. Consider them for comparative context: